Related Articles
Expression of stem cell factor in gastrointestinal stromal tumors: Implications for proliferation and imatinib resistance
Immortalization of human esophageal keratinocytes by E6 and E7 of human papillomavirus type 16
Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines
Knockdown of ubiquitin‑specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc‑finger E‑box binding homeobox 1
Secondary resistance to imatinib in patients with gastrointestinal stromal tumors through an acquired KIT exon 17 mutation